Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.

Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy

VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.

ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801

OCU400 is Ocugen’s novel modifier gene therapy for retinitis pigmentosa (RP). 

Ocugen signs term sheet for korean licensing of OCU400 gene therapy

Areas covered by the agreement would cover key Asian marketplaces, including Japan and China.

Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times – Clinical Insights for Eye Specialists

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Advances in Refractive Surgery: Spotlight on Small Incision Lenticule Extraction (SMILE) 

Video Series

Advances in Technology for SMILE procedure

Supported in part by ZEISS Professional Education. Content independently developed by Eye Care Network.

Videos

Dr. John Doane, MD, offers insights into Small Incision Lenticule Extraction (SMILE), highlighting its suitability for patients with myopia and astigmatism, and discussing the latest advancements in laser technology that enhance the surgical experience and precision of the procedure.

John Doane, MD, provides an overview of the SMILE procedure, highlighting its suitability for patients with myopia and astigmatism and what to expect postoperatively. 

Overview of Small Incision Lenticule Extraction (SMILE) 

John Doane, MD, discusses latest advancements in laser technology that enhance the surgical experience, speed, and precision of the SMILE procedure. 

Advances in Technology for SMILE procedure 

Advances in Technology for SMILE procedure

EP: 1.Overview of Small Incision Lenticule Extraction (SMILE)

EP: 2.Advances in Technology for SMILE procedure

Newsletter